These results deepen the knowledge about the possible regulation of the antioxidant role of HSA in diabetes and other pathophysiological conditions and enable the design of future HSA-drug studies which in turn is important for clinicians when designing information-based treatments. The gene discussed is ALB; the disease is diabetes mellitus.